Investors
See what the market has not priced in.
A compelling asset story can still rest on fragile assumptions about demand, provider behavior, differentiation or execution. We test the assumptions, not the narrative.
Questions we answer
- Is demand durable, or temporarily amplified?
- Is provider adoption realistic at this price?
- Does the product solve a problem the market feels?
- Can the differentiation support a premium?
- What hidden switching costs favor the incumbent?
- What happens when the category normalizes?
Method and inputs
Every conclusion is traceable to an input.
Clinical and product evidence
Trial design, endpoints, and what they do and do not prove.
Public financial and market data
Reported volume, pricing and category trajectory.
Primary and secondary research
Structured interviews against a stated sampling frame.
Provider and operator input
The people who decide whether a product travels.
Competitive benchmarking
How the incumbent has behaved when threatened before.
Assumptions and confidence
Stated explicitly, with the reasoning written out.
Example output
A profile, a verdict, and the reasoning behind both.
Reads are delivered as a written document: the scored profile, the material conclusions, the assumptions each rests on, and the confidence level attached to each.
The Marga Index™ does not replace investment judgment. It makes the commercial assumptions behind that judgment visible, comparable and challengeable.
Marga is founder led and supported by an expert network. We do not claim institutional scale, and we say so in writing when a question exceeds what the evidence supports.
Engagement shapes
Scoped to the decision in front of you.
- Asset diligence
- Category read
- Platform thesis
- Portfolio review